Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does a low urine F2-isoprostane-to-creatinine ratio suggest low systemic lipid peroxidation when urine creatinine is in range?

A low urine F2-isoprostane-to-creatinine ratio is directionally consistent with lower systemic lipid peroxidation, especially when urine creatinine is in range.

PlausibleAugust 21, 20264 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Low urine F2-isoprostane to creatinine ratio supports low systemic lipid peroxidation when urine creatinine is in range

laying out figure…
0 of 1 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

This claim says that a low creatinine-normalized urinary F2-isoprostane result points toward lower lipid peroxidation. The interpretation is framed as supportive rather than definitive because urine creatinine mainly helps control for dilution and does not remove all sources of variation. The mechanism reflects oxidative lipid injury being measured in urine, with confidence limited by creatinine handling, analyte choice, and assay method.

Verified conclusion

Low urinary F2-isoprostanes are widely used as an in-vivo signal of lower lipid peroxidation, but a single creatinine-normalized urine result is best viewed as supportive context rather than a definitive measure of whole-body oxidative burden.

Clinical interpretation

  • A low urine F2-isoprostane-to-creatinine ratio is directionally consistent with lower systemic lipid peroxidation. Creatinine normalization is standard for spot urine testing because it reduces variation caused by urine dilution.
  • Urine creatinine within the laboratory reference range modestly reduces concern that an extreme dilute or concentrated specimen is driving the ratio. It does not establish that creatinine normalization is fully unbiased for this individual.
  • The ratio should not be interpreted as proving low systemic lipid peroxidation: urinary isoprostanes are not organ-specific and can reflect renal production, metabolism, and excretion as well as systemic generation.

Mechanistic and analytical considerations

  • F2-isoprostanes arise from free-radical–mediated peroxidation of arachidonic acid, providing a biologically credible marker of oxidative lipid injury.
  • Creatinine generation and handling vary with muscle mass, diet, age, sex, kidney function, and renal physiology. These influences can persist despite a “normal” spot urine creatinine concentration.
  • The analyte matters: urinary 2,3-dinor-5,6-dihydro-8-iso-PGF2α may better capture integrated systemic isoprostane production than unmetabolized 8-iso-PGF2α alone.
  • Assay selection is important; mass-spectrometric methods are preferred over immunoassays, which may differ substantially in accuracy. Smoking can elevate urinary F2-isoprostanes by approximately twofold, and acute illness or strenuous exercise may transiently alter results.

Bottom line

  • A low creatinine-normalized urinary F2-isoprostane result plausibly supports lower lipid peroxidation, especially under standardized conditions, but normal urine creatinine is only a limited interpretive qualifier. Repeated first-morning samples, renal context, and the specific analyte and assay materially determine confidence in the inference.

References

  1. Urinary 8-isoprostane as a biomarker for oxidative stress. ... — pubmed.ncbi.nlm.nih.gov ↗
  2. Major metabolite of F2-isoprostane in urine may be a ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  3. Urinary biomarkers of oxidative status - Sci-Hub — 2024.sci-hub.box ↗
  4. Urinary F2-Isoprostanes and Metabolic Markers of Fat Oxidation - PMC — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→